Evaluating a cough-based algorithm for diagnosing COPD
A Clinical Validation Study to Evaluate the Diagnostic Accuracy of a Cough-based Auxiliary Diagnosis Algorithm for Chronic Obstructive Pulmonary Disease (COPD)
This study is testing a new tool that uses cough sounds to help diagnose COPD in patients so they can check their lung health at home.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 40 Years and up |
| Sex | All |
| Sponsor | Ruijin Hospital Academic / other |
| Locations | 1 site (Shanghai, Shanghai) |
| Trial ID | NCT06082791 on ClinicalTrials.gov |
What this trial studies
This study aims to validate a cough-based diagnostic algorithm designed to assist in the diagnosis of Chronic Obstructive Pulmonary Disease (COPD). By analyzing cough characteristics such as amplitude, frequency, and waveform, the algorithm seeks to provide an auxiliary diagnosis and predict lung function. The ultimate goal is to develop a portable tool that patients can use at home for rapid assessment of their condition. The study will involve patients with stable COPD to ensure accurate evaluation of the algorithm's performance.
Who should consider this trial
Good fit: Ideal candidates for this study are patients aged 40 and older with a stable diagnosis of COPD.
Not a fit: Patients experiencing acute exacerbations of respiratory symptoms or those with significant comorbid conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to a convenient and effective home-based tool for diagnosing and monitoring COPD.
How similar studies have performed: While the approach of using cough characteristics for diagnosis is innovative, similar studies have shown promise in utilizing algorithms for respiratory conditions, indicating potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients with stable COPD were recruited for this study. Inclusion criteria were age ≥40 years and a diagnosis of COPD Exclusion Criteria: * Exclusion criteria were acute exacerbations of respiratory symptoms within the past 2 weeks or significant comorbid cardiovascular, neurological, musculoskeletal, immunological, or infectious diseases.
Where this trial is running
Shanghai, Shanghai
- Ruijin Hospital, Shanghai Jiao Tong University School of Medicine — Shanghai, Shanghai, China (Recruiting)
Study contacts
- Study coordinator: Jiemin QU, pHD
- Email: 15390460355@163.com
- Phone: 15390460355
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.